← Leaderboards
Cory M. Hogaboam
University Of Michigan At Ann Arbor
$5,589,170
Attributed
$5,739,161
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,739,161 · 5
By mechanism
R01$4,396,082 · 3
P50$1,043,096 · 1
R43$299,983 · 1
Top collaborators
- Fabio Cohen Tucci1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Vibha N Lama$11,271,662
- Jennifer Ann Meddings$2,757,596
- Chad M Brummett$8,965,950
- Sunny Y Wong$7,036,918
- Jennifer Filip Waljee$8,693,885
Others in their field
Top investigators on “Fibroblasts”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$57,068,242
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$37,747,421
- Joseph C Wu · Stanford University$36,488,088
- Kristin Ardlie · Genomics Collaborative, Inc.$34,108,405
- Gail V Anderson · La Biomed Res Inst/ Harbor Ucla Med Ctr$27,497,410
- Joseph E Robertson · Oregon Health & Science University$27,496,135
Research focus
FibroblastsChronicInnovationChemokineMouse ModelDiagnosisLungMyofibroblastSignal TransductionCellsSamplingFibrosisPulmonary FibrosisDisease ProgressionBiopsyGenomicsDisease /Disorder ModelDisease PhenotypeDna-Dependent Protein KinaseGrantCytokineBehaviorAccelerationCytokine Receptors
Grant awards (16)
Novel agents for idiopathic pulmonary fibrosis$299,983
R43 · FY2020 · HL
Innate DNA sensing in rapidly progressing IPF$512,740
R01 · FY2018 · HL · contact PI
Innate DNA sensing in rapidly progressing IPF$508,004
R01 · FY2017 · HL · contact PI
Innate DNA sensing in rapidly progressing IPF$503,402
R01 · FY2016 · HL · contact PI
Innate DNA sensing in rapidly progressing IPF$498,937
R01 · FY2015 · HL · contact PI
IL-13 Fusion Cytotoxin as a Targeted Therapeutic for IIP$371,070
R01 · FY2006 · HL · contact PI
Chemokine and chemokine receptors in IPF$359,880
P50 · FY2006 · HL · contact PI
Therapeutic Targeting of RANTES/CCL5 in Fungal Asthma.$255,311
R01 · FY2006 · HL · contact PI
IL-13 Fusion Cytotoxin as a Targeted Therapeutic for IIP$427,200
R01 · FY2005 · HL
Chemokine and chemokine receptors in IPF$351,932
P50 · FY2005 · HL
Therapeutic Targeting of RANTES/CCL5 in Fungal Asthma.$263,252
R01 · FY2005 · HL
IL-13 Fusion Cytotoxin as a Targeted Therapeutic for IIP$267,750
R01 · FY2004 · HL
Therapeutic Targeting of RANTES/CCL5 in Fungal Asthma.$263,383
R01 · FY2004 · HL
IL-13 Fusion Cytotoxin as a Targeted Therapeutic for IIP$267,750
R01 · FY2003 · HL
Therapeutic Targeting of RANTES/CCL5 in Fungal Asthma.$257,283
R01 · FY2003 · HL
Chemokine and chemokine receptors in IPF$331,284
P50 · FY2002 · HL